Inhibikase updates presentation, highlights Phase 3 IKT-001 timelines
Inhibikase updated its corporate presentation to highlight progress on the Phase 3 IKT-001 program and anticipated clinical timelines.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.